UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Twelve-month efficacy and safety of omidenepag isopropyl, a selective EP2 agonist, in open-angle glaucoma and ocular hypertension: the RENGE study

Japanese journal of ophthalmology, 2021-11, Vol.65 (6), p.810-819

2021

Volltextzugriff (PDF)

Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study

Japanese journal of ophthalmology, 2020-07, Vol.64 (4), p.398-406

2020

Volltextzugriff (PDF)

Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)

Journal of ocular pharmacology and therapeutics, 2019-12, Vol.35 (10), p.542-550

2019

Volltextzugriff (PDF)

The relationship between the treatment zone diameter and visual, optical and subjective performance in Corneal Refractive Therapy™ lens wearers

Ophthalmic & physiological optics, 2007-11, Vol.27 (6), p.568-578

2007

Volltextzugriff (PDF)

Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study

American journal of ophthalmology, 2020-12, Vol.220, p.53

2020

Volltextzugriff (PDF)

FP and EP2 prostanoid receptor agonist drugs and aqueous humor outflow devices for treating ocular hypertension and glaucoma

Experimental eye research, 2023-04, Vol.229, p.109415-109415, Article 109415

2023

Volltextzugriff (PDF)

Reduction of myopia from corneal refractive therapy

Optometry and vision science, 2005-06, Vol.82 (6), p.512-518

2005

Volltextzugriff (PDF)

Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

Journal of glaucoma, 2019-05, Vol.28 (5), p.375-385

2019

Volltextzugriff (PDF)

Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension

American journal of ophthalmology, 2020-12, Vol.220, p.53-63

2020

Volltextzugriff (PDF)

Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL Study

Journal of ocular pharmacology and therapeutics, 2022-04, Vol.38 (3), p.240-251

2022

Volltextzugriff (PDF)

A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)

Journal of glaucoma, 2021-06, Vol.30 (6), p.473-480

2021

Volltextzugriff (PDF)

Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

Clinical ophthalmology (Auckland, N.Z.), 2024-07, Vol.18, p.2093-2106

2024

Volltextzugriff (PDF)

COETF Report: Biomechanical alteration of corneal morphology after Corneal Refractive Therapy

Canadian journal of optometry, 2021-10, Vol.68 (4)

Lu, Fenghe

2021

Volltextzugriff (PDF)

Corneal refractive therapy gas permeable lenses for the correction of hyperopia after one night of lens wear

Eye & contact lens, 2011-01, Vol.37 (1), p.26-30

2011

Volltextzugriff (PDF)

Malleability of the ocular surface in response to mechanical stress induced by orthokeratology contact lenses

Cornea, 2008-02, Vol.27 (2), p.133-141

2008

Volltextzugriff (PDF)

Corneal refractive therapy with different lens materials, part 2: effect of oxygen transmissibility on corneal shape and optical characteristics

Optometry and vision science, 2007-04, Vol.84 (4), p.349-356

2007

Volltextzugriff (PDF)

Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)

American journal of ophthalmology, 2024-07, Vol.263, p.23-34

2024

Volltextzugriff (PDF)

Corneal shape and optical performance after one night of corneal refractive therapy for hyperopia

Optometry and vision science, 2007-04, Vol.84 (4), p.357-364

2007

Volltextzugriff (PDF)

The relationship between the treatment zone diameter and visual, optical and subjective performance in Corneal Refractive Therapy™ lens wearers 1

Ophthalmic & physiological optics, 2007-11, Vol.27 (6), p.568-578

2007

Volltextzugriff (PDF)

The relationship between the treatment zone diameter and visual, optical and subjective performance in Corneal Refractive Therapy™ lens wearers1

Ophthalmic & physiological optics, 2007-11, Vol.27 (6), p.568-578

2007

Volltextzugriff (PDF)

Validity of pachymetric measurements by manipulating the acoustic factor of Orbscan II

Eye & contact lens, 2006-03, Vol.32 (2), p.78-83

2006

Volltextzugriff (PDF)

Biomechanical alteration of corneal morphology after corneal refractive therapy

Lu, Fenghe

2006

Volltextzugriff (PDF)

Immobilization of Sb in a smelting residue by micro-sized zero-valent iron: Long-term performance under accelerated exposure to strong acid rain

Chemosphere (Oxford), 2022-03, Vol.291 (Pt 1), p.132699-132699, Article 132699

2022

Volltextzugriff (PDF)

Integrinβ3 mediates the protective effects of soluble receptor for advanced glycation end-products during myocardial ischemia/reperfusion through AKT/STAT3 signaling pathway

Apoptosis (London), 2022-06, Vol.27 (5-6), p.354-367

2022

Volltextzugriff (PDF)

Expression and clinical value of PD‐L1 which is regulated by BRD4 in tongue squamous cell carcinoma

Journal of cellular biochemistry, 2020-02, Vol.121 (2), p.1855-1869

2020

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(26)

Publikationsform

Sprache

Englisch
(40)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Twelve-month efficacy and safety of omidenepag isopropyl, a selective EP2 agonist, in open-angle glaucoma and ocular hypertension: the RENGE study

Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study

Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)

The relationship between the treatment zone diameter and visual, optical and subjective performance in Corneal Refractive Therapy™ lens wearers

Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study

FP and EP2 prostanoid receptor agonist drugs and aqueous humor outflow devices for treating ocular hypertension and glaucoma

Reduction of myopia from corneal refractive therapy

Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension

Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL Study

A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)

Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

COETF Report: Biomechanical alteration of corneal morphology after Corneal Refractive Therapy

Corneal refractive therapy gas permeable lenses for the correction of hyperopia after one night of lens wear

Malleability of the ocular surface in response to mechanical stress induced by orthokeratology contact lenses

Corneal refractive therapy with different lens materials, part 2: effect of oxygen transmissibility on corneal shape and optical characteristics

Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)

Corneal shape and optical performance after one night of corneal refractive therapy for hyperopia

The relationship between the treatment zone diameter and visual, optical and subjective performance in Corneal Refractive Therapy™ lens wearers 1

The relationship between the treatment zone diameter and visual, optical and subjective performance in Corneal Refractive Therapy™ lens wearers1

Validity of pachymetric measurements by manipulating the acoustic factor of Orbscan II

Biomechanical alteration of corneal morphology after corneal refractive therapy

Immobilization of Sb in a smelting residue by micro-sized zero-valent iron: Long-term performance under accelerated exposure to strong acid rain

Integrinβ3 mediates the protective effects of soluble receptor for advanced glycation end-products during myocardial ischemia/reperfusion through AKT/STAT3 signaling pathway

Expression and clinical value of PD‐L1 which is regulated by BRD4 in tongue squamous cell carcinoma

Suchergebnisse filtern